切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2014, Vol. 03 ›› Issue (02) : 96 -99. doi: 10.3877/cma.j.issn.2095-3232.2014.02.008

所属专题: 文献

临床研究

原发性肝癌经导管动脉化疗栓塞术后患者症状困扰特点及其影响因素
王雪华1, 程文燕1, 张慧玲1, 黄师菊1,()   
  1. 1. 510630 广州,中山大学附属第三医院肝胆外科
  • 收稿日期:2013-12-01 出版日期:2014-04-10
  • 通信作者: 黄师菊
  • 基金资助:
    广东省科技计划项目(2012A020602002)

Characteristics of symptom distress and its influencing factors in patients with primary liver cancer after transcatheter arterial chemoembolization

Xuehua Wang1, Wenyan Cheng1, Huiling Zhang1, Shiju Huang1,()   

  1. 1. Department of Hepatobiliary Surgery, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
  • Received:2013-12-01 Published:2014-04-10
  • Corresponding author: Shiju Huang
  • About author:
    Corresponding author: Huang Shiju, Email:
引用本文:

王雪华, 程文燕, 张慧玲, 黄师菊. 原发性肝癌经导管动脉化疗栓塞术后患者症状困扰特点及其影响因素[J/OL]. 中华肝脏外科手术学电子杂志, 2014, 03(02): 96-99.

Xuehua Wang, Wenyan Cheng, Huiling Zhang, Shiju Huang. Characteristics of symptom distress and its influencing factors in patients with primary liver cancer after transcatheter arterial chemoembolization[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2014, 03(02): 96-99.

目的

探讨原发性肝癌(肝癌)经导管动脉化疗栓塞(TACE)术后患者症状困扰特点及其影响因素。

方法

根据自愿原则通过便利抽样法调查2012年1月至2013年1月在中山大学附属第三医院肝胆外科行TACE术后3 d的108例肝癌患者。其中男94例,女14例;年龄26~72岁,中位年龄51岁。所有患者调查前均签署知情同意书,符合医学伦理学规定。采用横断面研究和问卷调查的方法。问卷调查采用一般情况调查表、M.D.安德森症状评估量表(MDASI)、社会支持评定量表(SSS)、医学应对方式问卷(MCMQ)。症状困扰的影响因素分析采用多重线性回归分析。

结果

患者治疗期间MDASI症状分量表评分为(3.0±1.6)分,症状严重程度属轻度。症状对患者生活困扰分量表评分为(3.4±1.7)分,症状困扰程度亦属轻度。患者的工作受症状困扰最严重,其次为情绪、生活乐趣、一般活动、与他人关系、行走。困扰患者的最常见症状依次为发热、胃部不适、腹胀、皮肤黄染、体重减轻。患者的社会支持总评分为(42.2±6.7)分,为中等水平;社会支持的利用度评分为(7.9±2.2)分。患者的面对、回避、屈服3个维度评分分别为(2.5±0.5)、(2.4±0.5)、(2.0±0.6)分,较常采用的应对方式为面对和回避。大专及以上文化程度、患病后不在职、主观支持水平低、屈服应对的患者症状困扰程度较高(RR=0.320,0.254,0.569,0.217;P<0.05)。

结论

肝癌TACE术后患者存在轻度的症状困扰,大专及以上文化程度、患病后不在职、主观支持水平低、屈服应对的患者症状困扰程度较高。

Objective

To study the characteristics of symptom distress and its influencing factors in patients with primary liver cancer after transcatheter arterial chemoembolization (TACE).

Methods

A total of 108 patients with primary liver cancer receiving TACE in Department of Hepatobiliary Surgery, the Third Affiliated Hospital of Sun Yat-sen University from January 2012 to January 2013 were voluntarily enrolled in this study on the 3rd day after operation by convenience sampling method. There were 94 males and 14 females with age ranging from 26 to 72 years old and median age of 51 years old. The informed consents of all patients were obtained and the ethics committee approval was received. Cross-sectional study and questionnaire survey were used in the research. The questionnaire survey included questionnaire of general information, M.D. Anderson Symptom Inventory (MDASI), Social Support Measuring Questionnaire (SSS) and Medical Coping Modes Questionnaire (MCMQ). Multiple linear regression analysis was used to identify factors influencing the symptom distress.

Results

The mean score of MDASI symptom subscale of patients during therapy was 3.0±1.6 with a mild degree of symptom distress. The score of MDASI life distress subscale of patients was 3.4±1.7, also with a mild degree of symptom distress. Work was most influenced by the symptoms, followed by emotion, joy of life, common activity, relation with others and walks. Fever, discomfort of stomach, abdominal distention, icteric skins and weight loss were common symptoms in sequence which distressed patients. The total score of social support was 42.2±6.7 which was at the middle level, and the sore of use of social support was 7.9±2.2. The score of 3 dimensions facing, avoiding, surrender were 2.5±0.5, 2.4±0.5, 2.0±0.6 respectively. Facing and avoiding were the common coping modes. Patients who had college educational degree or above, no job after being ill, low level of subjective support, surrender coping mode were more distressed by symptoms than the other patients (RR=0.320, 0.254, 0.569, 0.217; P<0.05).

Conclusions

Patients with primary liver cancer have mild symptom distress after TACE, and patients with college educational degree or above, no job after being ill, low level of subjective support, surrender coping mode are more distressed by symptoms than the other patients.

表1 肝癌经导管动脉化疗栓塞术后患者症状困扰影响因素的多重线性回归分析结果
[1]
吴孟超, 郑伟达.原发性肝癌中西医结合治疗学[M].北京: 人民卫生出版社, 2011.
[2]
孟炜,陆鸿雁,蔡如琳, 等.原发性肝癌的遗传流行病学研究[J].中华流行病学杂志, 2002, 23(6): 438-440.
[3]
Kuo TT,Ma FC. Symptom distresses and coping strategies in patients with non-small cell lung cancer[J]. Cancer Nurs, 2002, 25(4): 309-317.
[4]
McCorkle R,Young K. Development of a symptom distress scale[J]. Cancer Nurs, 1978, 1(5): 373-378.
[5]
Cleeland CS,Mendoza TR,Wang XS, et al. Assessing symptom distress in cancer patients: the MD. Anderson Symptom Inventory[J].. Cancer, 2000, 89(7): 1634-1646.
[6]
Lin CC,Chang AP,Cleeland CS, et al. Taiwanese version of the MD. Anderson Symptom Inventory: symptom assessment in cancer patients[J].. J Pain Symptom Manage, 2007, 33(2): 180-188.
[7]
肖水源.《社会支持评定量表》的理论基础与研究应用[J].临床精神医学杂志, 1994, 4(2): 98-100.
[8]
沈晓红,姜乾金.医学应对方式问卷中文版701例测试报告[J].中国行为医学科学, 2000, 9(1): 18.
[9]
Lam WW,Bonanno GA,Mancini AD, et al. Trajectories of psychological distress among Chinese women diagnosed with breast cancer[J]. Psychooncology, 2010, 19(10): 1044-1051.
[10]
韩鹏飞,张劲松.中晚期肝癌介入治疗后常见近期并发症的meta分析[J].上海预防医学, 2007, 19(10): 517-519.
[11]
金健行,高发年,程永德,等.220例次肝动脉导管化疗栓塞术的副反应和并发症分析及其对策[J].新医学, 1995, 26(2): 65-66.
[12]
Sarna L,Cooley ME,Brown JK, et al. Symptom severity 1 to 4 months after thoracotomy for lung cancer[J]. Am J Crit Care, 2008, 17(5): 455-467.
[13]
张成武,赵大建,胡智明,等.原发性肝癌经肝动脉栓塞化疗术后预后指标的多因素分析[J].肝胆胰外科杂志, 2007, 19(6): 376-379.
[14]
余正平,张启瑜.肝动脉化疗栓塞在原发性肝癌外科治疗中的地位和作用[J].肝胆胰外科杂志, 2003, 15(1): 65-67.
[15]
廖苑,周英,曾丽珍,等.肝移植术后患者的生存质量及其影响因素研究[J/CD].中华肝脏外科手术学电子杂志,2012,1(2):103-108.
[16]
赵鑫,刘华平.乳腺癌化疗病人应对方式及影响因素的研究[J].护理研究, 2008, 22(24): 2176-2177.
[1] 中国医师协会肝癌专业委员会. 肝细胞癌伴微血管侵犯诊断和治疗中国专家共识(2024版)[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 313-324.
[2] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[3] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[4] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[5] 陆朝阳, 金也, 孙备. 腹腔镜解剖性肝切除的发展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 363-366.
[6] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[7] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[8] 刘敏思, 李荣, 李媚. 基于GGT与Plt比值的模型在HBV相关肝细胞癌诊断中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 831-835.
[9] 焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.
[10] 陈晓鹏, 王佳妮, 练庆海, 杨九妹. 肝细胞癌VOPP1表达及其与预后的关系[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 876-882.
[11] 袁雨涵, 杨盛力. 体液和组织蛋白质组学分析在肝癌早期分子诊断中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 883-888.
[12] 吴警, 吐尔洪江·吐逊, 温浩. 肝切除术前肝功能评估新进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 889-893.
[13] 邓万玉, 陈富, 许磊波. 肝硬化与非肝硬化乙肝相关性肝癌患者术后无复发生存比较及其影响因素分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 670-674.
[14] 王向前, 李清峰, 陈磊, 丘文丹, 姚志成, 李熠, 吴荣焕. 姜黄素抑制肝细胞癌索拉非尼耐药作用及其调控机制[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 729-735.
[15] 中华人民共和国国家卫生健康委员会医政司. 原发性肝癌诊疗指南(2024年版)[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 407-449.
阅读次数
全文


摘要